David McIntyre - Chief Financial Officer at Inhibikase Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
IKT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David McIntyre since 10/19/2024

Holdings reported by David McIntyre for Inhibikase Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 10.3K $14.1K $1.37 Apr 14, 2025 Direct
Stock Option (Right to Buy) 1.78M Apr 14, 2025 Direct Common Stock

Transactions reported by David McIntyre for Inhibikase Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.